Literature DB >> 22995311

Functional cloning of Vibrio parahaemolyticus type III secretion system 1 in Escherichia coli K-12 strain as a molecular syringe.

Yukihiro Akeda1, Tomomi Kimura, Aiko Yamasaki, Toshio Kodama, Tetsuya Iida, Takeshi Honda, Kazunori Oishi.   

Abstract

The type III secretion system (T3SS) of gram-negative bacteria involves dedicated protein translocation machinery that directly injects proteins into target cells. Pathogenic bacteria already benefit from this unique system. The successful functional cloning of this useful tool into non-pathogenic bacteria would help establish novel clinical and basic biotechnology strategies in areas such as vaccine administration, the development of screening systems for anti-T3SS drugs and the target-specific delivery of bioactive compounds. In this study, we successfully cloned the Vibrio parahaemolyticus T3SS1 genetic locus into a non-pathogenic Escherichia coli K-12 strain. Assays performed here revealed that the T3SS1 cloned into the E. coli K-12 strain has the ability to translocate V. parahaemolyticus T3SS1 secreted proteins. Importantly, we also observed this system to allow the E. coli K-12 strain to inject foreign protein, as well as the V. parahaemolyticus T3SS effector, into cultured cells. These results demonstrate a prospective useful tool with experimental and therapeutic applications.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22995311     DOI: 10.1016/j.bbrc.2012.09.018

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Rationale redesign of type III secretion systems: toward the development of non-pathogenic E. coli for in vivo delivery of therapeutic payloads.

Authors:  Coral González-Prieto; Cammie F Lesser
Journal:  Curr Opin Microbiol       Date:  2017-11-12       Impact factor: 7.934

2.  Engineering Escherichia coli into a protein delivery system for mammalian cells.

Authors:  Analise Z Reeves; William E Spears; Juan Du; Kah Yong Tan; Amy J Wagers; Cammie F Lesser
Journal:  ACS Synth Biol       Date:  2015-04-24       Impact factor: 5.110

Review 3.  Intracellular delivery of biologic therapeutics by bacterial secretion systems.

Authors:  Barnabas James Walker; Guy-Bart V Stan; Karen Marie Polizzi
Journal:  Expert Rev Mol Med       Date:  2017-04-06       Impact factor: 5.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.